Combinatorial strategies for the induction of immunogenic cell death. - Test2 - elhamkhani - TriplyDB

Combinatorial strategies for the induction of immunogenic cell death.

Combinatorial strategies for the induction of immunogenic cell death.

http://www.wikidata.org/entity/Q35535140

about

Big Data Offers Novel Insights for Oncolytic Virus Immunotherapy Exploiting the Immunomodulatory Properties of Chemotherapeutic Drugs to Improve the Success of Cancer Immunotherapy Concepts and mechanisms underlying chemotherapy induced immunogenic cell death: impact on clinical studies and considerations for combined therapies Prognostic and Predictive Value of DAMPs and DAMP-Associated Processes in Cancer Combination Approaches with Immune-Checkpoint Blockade in Cancer Therapy The Impact of Chemotherapy, Radiation and Epigenetic Modifiers in Cancer Cell Expression of Immune Inhibitory and Stimulatory Molecules and Anti-Tumor Efficacy Immunogenic versus tolerogenic phagocytosis during anticancer therapy: mechanisms and clinical translation Programmed cell death 50 (and beyond)Immunotherapy in head and neck cancer: aiming at EXTREME precision.Autophagic Mechanism in Anti-Cancer Immunity: Its Pros and Cons for Cancer Therapy.IDO in the Tumor Microenvironment: Inflammation, Counter-Regulation, and Tolerance Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death.CpG-1826 immunotherapy potentiates chemotherapeutic and anti-tumor immune responses to metronomic cyclophosphamide in a preclinical glioma model IFN-α potentiates the direct and immune-mediated antitumor effects of epigenetic drugs on both metastatic and stem cells of colorectal cancer.Calreticulin exposure by malignant blasts correlates with robust anticancer immunity and improved clinical outcome in AML patients.Late-stage inhibition of autophagy enhances calreticulin surface exposure.Immunogenic cancer cell death selectively induced by near infrared photoimmunotherapy initiates host tumor immunity.Effects of mannose-binding lectin on pulmonary gene expression and innate immune inflammatory response to ozone.Immune suppressive mechanisms in the tumor microenvironment.Autophagy, Inflammation, and Immunity: A Troika Governing Cancer and Its Treatment.Repurposing platinum-based chemotherapies for multi-modal treatment of glioblastoma.IDO, PTEN-expressing Tregs and control of antigen-presentation in the murine tumor microenvironment.The novel immunomodulator IMMUNEPOTENT CRP combined with chemotherapy agent increased the rate of immunogenic cell death and prevented melanoma growth.Short Term Hypoxia Synergizes with Interleukin 15 Priming in Driving Glycolytic Gene Transcription and Supports Human Natural Killer Cell Activities Invariant Natural Killer T Cells in Immune Regulation of Blood Cancers: Harnessing Their Potential in Immunotherapies.Nano-enabled pancreas cancer immunotherapy using immunogenic cell death and reversing immunosuppression.Temporally Programmed CD8α+ DC Activation Enhances Combination Cancer Immunotherapy.No patient left behind: The promise of immune priming with epigenetic agents.Establishment of Synergistic Chemoimmunotherapy for Head and Neck Cancer Using Peritumoral Immature Dendritic Cell Injections and Low-Dose Chemotherapies.Trial watch: Immune checkpoint blockers for cancer therapy.Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018.Progress in Vaccine Therapies for Breast Cancer.Chemo-Immunotherapy: Role of Indoleamine 2,3-Dioxygenase in Defining Immunogenic Versus Tolerogenic Cell Death in the Tumor Microenvironment.Dinaciclib induces immunogenic cell death and enhances anti-PD1-mediated tumor suppression.A safe and highly efficient tumor-targeted type I interferon immunotherapy depends on the tumor microenvironment.Dying to Be Noticed: Epigenetic Regulation of Immunogenic Cell Death for Cancer Immunotherapy.Neutrophil: A Cell with Many Roles in Inflammation or Several Cell Types?CX3CR1 identifies PD-1 therapy-responsive CD8+ T cells that withstand chemotherapy during cancer chemoimmunotherapy.Trial watch: Dendritic cell-based anticancer immunotherapy.Targeting Autophagy for Oncolytic Immunotherapy.

P2860

Q26767209-35F17DBF-FB85-4F6B-8A1B-55C5970F1ECD Q26779184-EE94F114-CBE3-47BA-970F-D65F38E4E610 Q26781215-4C2FF3A3-F5FC-4024-87DE-1F593C70AA8F Q26795466-ADF0555E-FC17-48F2-B86F-7D26A725C152 Q28066199-71C84971-82E0-4E59-B755-42B663121312 Q28076473-4C1C9A08-CEDC-4B5F-94F2-DA6F473F6609 Q28386858-7ACA083C-A1D1-465A-839F-8AC0EBD201C9 Q28601538-9CA31D4C-9DA3-4156-9936-1A799A4B060B Q33756244-EEC70293-4088-4AC9-9DAB-CD6B81E63118 Q33839054-C010E19E-7B73-43B5-A201-5EAA484FF219 Q34512092-CD5F810F-6C96-4BBE-8FC8-D4A29CD26F3C Q36301061-143F68E3-3E5A-4688-A195-B77A352A5B78 Q36600960-A23B334C-F2FF-4177-8E84-12D303CB0AC6 Q37295663-C65685E4-0AE6-45C6-8B83-53C6E41E170C Q37545824-69F11481-D795-4057-BCF9-C553F461EB60 Q37697081-531811AC-674E-4E3C-BB2F-3B5FDAC1F404 Q37705851-A21DD89C-4CDD-483B-A20C-BB987515D836 Q38448249-BEB9D5FE-3AA2-449C-9F75-BF511AB45C4D Q38648567-F8F12196-CDE6-4DDE-AB5C-BF78869EF6AF Q38897741-0839B7BC-ACF5-451F-AFAF-2D696F915386 Q38984857-57061AEB-7C0E-4103-BC62-E60B1161798D Q39294822-F43938B3-A7D0-458F-983F-093E57769888 Q40128947-601984E5-AD20-40CC-BD67-AA06A8A02747 Q40693797-8229065C-32FA-43BE-AB42-F593BCBF6E2A Q43555934-A890FB8B-6469-414A-9EC5-3FEC1852852D Q46014755-54883C0E-CAB4-444F-9601-5E2FA8645F6C Q46411313-2B4A7E1D-93DA-4453-96AC-039E9A5715B9 Q46665179-BB66CE5A-FDCE-44ED-8695-AE4ACFA37077 Q47096374-F3488643-A2A6-430B-879A-F288E16A4FDA Q47393365-CD1CB402-3DC9-4BDD-9440-428F9790EA02 Q47843948-F2BC9924-A9C9-4C00-BC19-CE080E92629B Q48556381-303957F5-A7FD-4BFC-8359-8EB5F90C6D65 Q49592881-A7841AC9-38FE-48A0-B58A-9A352469A1DC Q50031768-71F90E11-EAC8-46AD-9D0E-A8EAC2F56A0F Q50538951-E6368F0B-7DC1-48AF-AF5F-48095420DA18 Q52581847-F6373F67-91FE-42A3-B804-737894D4BAFA Q52668399-840E7737-C19E-4B38-AC12-40D5B40C6591 Q52718482-74C5AAF3-C658-4D77-8D85-E78B89269222 Q53109846-D521168A-BBEF-4C66-8AE7-159A1BB92746 Q55171421-E86F7D80-22A8-40C7-8B81-8B6A63D7A07B

P2860

Combinatorial strategies for the induction of immunogenic cell death.

http://www.wikidata.org/entity/Q35535140

description

2015 nî lūn-bûn

@nan

2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Combinatorial strategies for the induction of immunogenic cell death.

@ast

Combinatorial strategies for the induction of immunogenic cell death.

@en

type

label

Combinatorial strategies for the induction of immunogenic cell death.

@ast

Combinatorial strategies for the induction of immunogenic cell death.

@en

prefLabel

Combinatorial strategies for the induction of immunogenic cell death.

@ast

Combinatorial strategies for the induction of immunogenic cell death.

@en

P1433

Q35535140-E785CFA3-0E31-4C67-A5B1-9017EE9F7848

P1476

Q35535140-CBB8591E-44F5-4649-B213-BC68777F6B57

P2093

Q35535140-949888E0-11EE-4843-9DDC-59CC499CFD56

Q35535140-A1E67B62-9369-4C2D-8331-D76AE4B465D0

Q35535140-B5C8ABCD-D893-43AF-84DB-C0C1EA0B6533

Q35535140-BCBF93EB-BE41-48DF-8948-E72E32324F7E

P2860

Q35535140-0057D8F0-28AF-4796-BFBE-67F45676EEFC

Q35535140-02332EDF-AC2A-43A2-94D8-A16671E6AD7A

Q35535140-06FC4321-9985-4C25-ABB5-5D3E43089A1D

Q35535140-08396E4D-E94E-4A59-BF53-C8E27AC67CCB

Q35535140-09E855C7-BA48-4122-83EE-E2B00E43C690

Q35535140-0A3D86E1-EF11-49E1-B98E-49E3CD4692EC

Q35535140-0A6DC25F-AF6C-42A1-8AA9-579ABB3EA09A

Q35535140-0BEB5A35-F8D7-46ED-B2D7-69330B0ADEA7

Q35535140-0C40FBCB-5117-43E5-B6A2-42010E6FB602

Q35535140-0DBC0817-7022-4863-8725-C5347117BEA8

P304

Q35535140-A5AFFBDE-DCA0-46FB-8DF8-AFD9B8FA3E38

P31

Q35535140-6CC54578-BBBA-4D77-BEA1-DF9F144F284F

P356

Q35535140-CB8F1B82-2A83-4785-B73E-F8591E91ED9D

P478

Q35535140-6B170D17-BC18-4045-BBDE-2C04449823EC

P50

Q35535140-244B4E39-2C99-4CBA-9FF8-11522A306FB9

Q35535140-9B10B1CF-5127-473C-84A6-A9BE3F8A312E

Q35535140-B65C4DE0-9416-4A4F-A44C-29CA6896C221

Q35535140-C16368DB-5C32-4B47-BFB3-F4518527B89B

Q35535140-E89FDBE7-DB58-4E6D-AF17-CDD2A6E0D020

P577

Q35535140-7A7A2A0F-815C-485A-A2B7-C0D3472CA709

P5875

Q35535140-363AB527-6890-4F00-9222-157B86BBF447

P698

Q35535140-A31FCD20-BC71-4B66-92B0-CB5D1E621E7A

P932

Q35535140-112E1813-F38E-4EC9-AEDB-5AF74CDE69C6

P356

FIMMU.2015.00187

P1433

Frontiers in Immunology

P1476

Combinatorial strategies for the induction of immunogenic cell death.

@en

P2093

Jitka Fucikova

http://www.w3.org/2001/XMLSchema#string

Ligia C Gomes-de-Silva

http://www.w3.org/2001/XMLSchema#string

Lucillia Bezu

http://www.w3.org/2001/XMLSchema#string

Radek Spisek

http://www.w3.org/2001/XMLSchema#string

P2860

A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death

Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009

Regulation of type I interferon responses

Mitochondria and the autophagy-inflammation-cell death axis in organismal aging

Autophagy in malignant transformation and cancer progression

Trial Watch:: Oncolytic viruses for cancer therapy

Ipilimumab plus dacarbazine for previously untreated metastatic melanoma

The hallmarks of aging

Release of chromatin protein HMGB1 by necrotic cells triggers inflammation

High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal

P304

187

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FIMMU.2015.00187

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Lorenzo Galluzzi

Karine Breckpot

P577

2015-04-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

275723068

http://www.w3.org/2001/XMLSchema#string

P698

25964783

http://www.w3.org/2001/XMLSchema#string

P932

4408862

http://www.w3.org/2001/XMLSchema#string